Evaluate the Long-Term Safety and Efficacy of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia
Clinical trial NCT03409744 · COMPLETED
Trial details
- NCT number
- NCT03409744
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-13
- Primary completion
- 2023-04-13
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.